Skip to content

Replimune Group REPL Finance Lease, Right-of-Use Asset, after Accumulated Amortization

Finance Lease, Right-of-Use Asset, after Accumulated Amortization at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
Incyte logo
IncyteINCY
Moderna logo
ModernaMRNA

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$930.59M+28.6%
Enterprise value$885.15M+28.3%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseRightOfUseAsset.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's finance lease, right-of-use asset, after accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Replimune Group's finance lease, right-of-use asset, after accumulated amortization?
Replimune Group (REPL) reported finance lease, right-of-use asset, after accumulated amortization of $32.99M in Q4 2025.
How has Replimune Group's finance lease, right-of-use asset, after accumulated amortization changed year-over-year?
Replimune Group's finance lease, right-of-use asset, after accumulated amortization decreased by 6.9% year-over-year, from $35.42M to $32.99M.
What is the long-term trend for Replimune Group's finance lease, right-of-use asset, after accumulated amortization?
Over 4 years (2021 to 2025), Replimune Group's finance lease, right-of-use asset, after accumulated amortization has grown at a -6.0% compound annual growth rate (CAGR), from $44.52M to $34.81M.